10x Genomics, Inc. provided revenue guidance for the fourth quarter of 2025. The company expects fourth quarter 2025 revenue to be in the range of $154 million to $158 million, representing a 6% decline from the corresponding prior year period and 5% growth sequentially at the midpoint.
10X Genomics, Inc. Provides Revenue Guidance for the Fourth Quarter of 2025
Published on 11/06/2025 at 04:05 pm EST
S&P Capital IQ
Share
© S&P Capital IQ -
2025
Share

















